Ovid Therapeutics Inc.
OVID · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $7.25M | $570K | +1,172% |
| Operating income | −$42.4M | −$61.9M | +31.4% |
| Net income | −$17.4M | −$26.4M | +34.1% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $100K | −100% |
| Operating income | −$22.4M | −$12.5M | −79.2% |
| Net income | −$20.8M | −$12.2M | −70.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Ovid Therapeutics's revenue in FY2025?
- $7.25M in FY2025 (Fiscal year ended Dec 31, 2025), +1,172% vs $570K a year earlier, per its 10-K filed Mar 2026.
- Was Ovid Therapeutics profitable in FY2025?
- No: net income was −$17.4M and operating income −$42.4M in FY2025.
- What was Ovid Therapeutics's revenue in Q3 2026?
- $0K (−100% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.